cyclosporine has been researched along with Mast-Cell Sarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bleackley, RC; Brooks-Kaiser, J; Fitzpatrick, L; Hoskin, DW; Kaiser, M | 1 |
Ceuppens, JL; Coorevits, L; Kasran, A; Peng, X; Rafiq, K; Van Gool, SW; Warmerdam, PA | 1 |
2 other study(ies) available for cyclosporine and Mast-Cell Sarcoma
Article | Year |
---|---|
Cytotoxic cell proteinase gene expression and cytolytic activity by anti-CD3-activated cytotoxic T lymphocytes is sensitive to cyclosporin A but is not dependent on interleukin-2 synthesis.
Topics: Animals; Antibodies, Monoclonal; Blotting, Northern; CD3 Complex; Cell Line; Cyclosporine; Cytotoxicity, Immunologic; Gene Expression; Interleukin-2; Lymphocyte Activation; Male; Mast-Cell Sarcoma; Mice; Mice, Inbred CBA; RNA, Messenger; Serine Endopeptidases; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured | 1993 |
Cyclosporin A increases IFN-gamma production by T cells when co-stimulated through CD28.
Topics: Adjuvants, Immunologic; Animals; CD28 Antigens; CD3 Complex; CD4-Positive T-Lymphocytes; Cyclosporine; Drug Resistance; Humans; Interferon-gamma; Interleukin-10; Interleukin-2; Interleukin-4; Lymphocyte Activation; Mast-Cell Sarcoma; Mice; RNA, Messenger; Signal Transduction; T-Lymphocytes; Tumor Cells, Cultured | 1998 |